Glioma models: new GEMMs add "class" with genomic and expression correlations

Cécile L Maire1, Keith L Ligon

  • 1Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. keith_ligon@dfci.harvard.edu

Cancer Cell
|March 15, 2011
PubMed
Summary

Combinatorial loss of TP53, PTEN, and RB1 tumor suppressors in mice induces malignant gliomas. These experimentally-induced gliomas closely mimic human glioma subclasses identified through large-scale genomic studies.